Skip to main content

Liver Treatment Market Analysis 2018-2025: Key Findings, Regional Analysis, Key Players Profiles and Future Prospects

Press release   •   Oct 01, 2019 09:59 IST

Liver Treatment Market

The global liver treatment market is expected to reach US$ 4,883.5 Mn in 2025 from US$ 3,426.8 Mn in 2017. The market is estimated to grow with a CAGR of 4.6% from 2018-2025.

Key factors such as increasing prevalence of liver diseases, rising geriatric population suffering from liver diseases and various technological advancements in imaging techniques are key drivers for the growth of the market. However, factors such as stringent regulatory framework and high cost of imaging techniques for liver treatment are likely to restrain the market growth to a certain extent. One the other hand, partnerships and collaborations among industry players and increasing expenditures among emerging markets are expected to provide significant opportunities to the players in the liver treatment market.

Get PDF sample copy of this Study: https://www.theinsightpartners.com/sample/TIPMD00002089/

Key market players operating in the market of liver treatment across the globe includes General Electric, Koninklijke Philips N.V., Siemens AG, CANON MEDICAL SYSTEMS CORPORATION, Hitachi, Ltd, Elekta AB (pub), Neusoft Corporation, Samsung Healthcare, BPL Medical Technologies, and Cura Healthcare. 

The manufacturing companies are launching innovative products in the market to retain their significance in the highly competitive global scenario. For instance, in November 2017, Canon Medical Systems introduced the new package for its iSeries scanners. The series will include Aplio i700, i800, and i900 which will be assessing the liver in the patients suffering from fatty liver diseases. The developments performed by the companies are helping the market to grow in the coming years.

Technological advancements in imaging systems is driving the market for Liver treatment over the forecast period

Global liver treatment market, based on the diseases, is segmented into cancer, hepatitis, cirrhosis, and other diseases. In 2017, cancer held the largest market share. There has been a significant increase in the number of liver cancer cases due to hepatitis infections, smoking, over consumption of alcohol, and obesity. Cancer is also expected to be the fastest growing segment and is likely to grow at the highest growth rate during the forecast period. This attributes to the rapidly increasing number of patients suffering with the disease that requires appropriate diagnosis and treatment options.

Buy the complete report with Comprehensive table of contents @ https://www.theinsightpartners.com/buy/TIPMD00002089/

The report analyzes factors affecting market from both demand and supply side and further evaluates liver treatment market dynamics effecting the liver treatment market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key manufacturing companies along with their SWOT analysis and market strategies.

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.

Comments (0)

Add comment

Comment

By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.